CABB Group Archives | Market Krystal

CABB expands Univar distribution deal to cover North America

admin — Thu, 01 Oct 2026 12:30:20 +0000

German personal care ingredient maker CABB Group has expanded its exclusive distribution agreement with Univar Solutions to cover North America. The extension gives Univar exclusive distribution rights for CABB's personal care ingredients across the region.

Why it matters

Univar's exclusive North American rights would route CABB personal care ingredients to regional formulators through a single distributor, shifting local supply and competitive access for rival ingredient suppliers.

Key facts

Companies	CABB Group, Univar Solutions
Timing	October 1, 2026
Partners	Univar Solutions
End uses	Personal care

Market context

Personal care ingredients are specialty chemicals used in formulations such as skin care, hair care, and cosmetics, where they act as emulsifiers, surfactants, conditioning agents, or active components. Demand for these ingredients is driven mainly by consumer personal care brands, which often prefer dependable regional sourcing, consistent quality documentation, and technical support from their suppliers. When a manufacturer routes its ingredients through one distributor in a region, it changes how formulators buy and how quickly they can get samples and volumes. Exclusive distribution can concentrate channel access, which may make it harder for rival ingredient suppliers to win listings with local customers. For buyers, the practical effects usually center on lead times, pricing structure, and which technical service channels they can use. For investors, such arrangements signal how a specialty ingredient maker is choosing to manage market reach rather than changing production output.

Source: official release on cabb-chemicals.com. Summary and context written by Market Krystal.

The post CABB expands Univar distribution deal to cover North America appeared first on Market Krystal.

Univar Solutions Gains Exclusive North American Glycolic Acid Distribution From CABB

admin — Thu, 01 Oct 2026 12:22:43 +0000

Univar Solutions has signed an exclusive distribution agreement with CABB Group covering the United States and Canada, giving it North American access to CABB's glycolic acid portfolio, including Glycos Clear 70. The deal extends an existing EMEA relationship between the two companies into North America. The product is aimed at the beauty market, where glycolic acid is seeking a broader distribution route.

Why it matters

Exclusive distribution of CABB's glycolic acid through Univar in the US and Canada could shift regional supply channels and competition for beauty-grade glycolic acid customers.

Key facts

Companies	CABB Group, Univar Solutions
Chemicals	Glycolic acid, Glycos Clear 70
Timing	2026-10-09, October 1, 2026
Partners	Univar Solutions
End uses	Beauty market

Market context

Glycolic acid is the smallest alpha-hydroxy acid and is widely used in personal care products, where it acts as an exfoliant and pH adjuster in skin care formulations. Beauty and personal care brands are the main demand drivers, with additional use in cleaning products, textile processing, and industrial applications such as metal cleaning. Because product quality requirements differ by grade, buyers in cosmetics often weigh purity, consistency, and documentation alongside price. Exclusive distribution arrangements can concentrate sales through a single channel partner, which may change how regional customers source material and how competing suppliers and distributors position their offerings. For buyers and investors, changes in distribution access for specialty acids tend to matter most in regions where supply options were previously limited, since they can affect lead times, availability, and negotiating leverage over time.

Source: official release on cabb-chemicals.com. Summary and context written by Market Krystal.

The post Univar Solutions Gains Exclusive North American Glycolic Acid Distribution From CABB appeared first on Market Krystal.

CABB Group and XNA Pharma article links DCA route to oligonucleotide purity

admin — Fri, 11 Sep 2026 09:10:55 +0000

CABB Group, with XNA Pharma, presents an article on why dichloroacetic acid (DCA) quality determines oligonucleotide synthesis performance. The piece, authored by Dr Christian Schulz of CABB and Professor Tobias Pöhlmann of XNA Pharma, focuses on how the DCA manufacturing route influences purity. It appears in the Sep/Oct 2026 issue of SpecChem Online.

Key facts

Companies	CABB Group, XNA Pharma, SpecChem Online
Chemicals	dichloroacetic acid (DCA), oligonucleotides
Timing	2026-09-11, Sep/Oct 2026
Partners	XNA Pharma
End uses	oligonucleotide synthesis

Market context

Dichloroacetic acid is a small chlorinated carboxylic acid used as a building block and reagent in fine and specialty chemical synthesis. In oligonucleotide manufacturing, it is used in the deprotection and detritylation steps of solid-phase synthesis, so impurities carried in the reagent can affect the purity of the final therapeutic or diagnostic strand. Demand for high-purity grades is driven mainly by the pharmaceutical sector, particularly the growing antisense, siRNA and other nucleic acid drug pipelines, along with research and diagnostic uses. For buyers, the production route and the impurity profile it leaves behind are often as important as the nominal assay. Tighter specifications can narrow the pool of qualified suppliers, shift purchasing toward producers with documented process control, and influence pricing for premium pharmaceutical-grade material relative to technical grades.

Source: official release on cabb-chemicals.com. Summary and context written by Market Krystal.

The post CABB Group and XNA Pharma article links DCA route to oligonucleotide purity appeared first on Market Krystal.